Tumor-cell resistance to death receptor???induced apoptosis through mutational inactivation of the proapoptotic Bcl-2 homolog Bax, Nature Medicine, vol.8, issue.3, pp.274-81, 2002. ,
DOI : 10.1038/nm0302-274
DcR2 (TRAIL-R4) siRNA and adenovirus delivery of TRAIL (Ad5hTRAIL) break down in vitro tumorigenic potential of prostate carcinoma cells, Cancer Gene Therapy, vol.16, issue.12, pp.976-84, 2007. ,
DOI : 10.1038/sj.cgt.7701087
TRAIL Death Receptor???4 Expression Positively Correlates With the Tumor Grade in Breast Cancer Patients With Invasive Ductal Carcinoma, International Journal of Radiation Oncology*Biology*Physics, vol.69, issue.3, pp.716-739, 2007. ,
DOI : 10.1016/j.ijrobp.2007.03.057
TRAIL decoy receptors mediate resistance of acute myeloid leukemia cells to TRAIL ,
Intracellular regulation of TRAIL-induced apoptosis in human melanoma cells, J Immunol, vol.161, issue.6, pp.2833-2873, 1998. ,
Differential Inhibition of TRAIL-Mediated DR5-DISC Formation by Decoy Receptors 1 and 2, Molecular and Cellular Biology, vol.26, issue.19 ,
DOI : 10.1128/MCB.00520-06
URL : https://hal.archives-ouvertes.fr/inserm-00103839
CD40 Ligand Protects from TRAIL-Induced Apoptosis in Follicular Lymphomas through NF-??B Activation and Up-Regulation of c-FLIP and Bcl-xL, The Journal of Immunology, vol.181, issue.2, pp.1001-1012, 2008. ,
DOI : 10.4049/jimmunol.181.2.1001
Multidomain Bcl-2 homolog Bax but not Bak mediates synergistic induction of apoptosis by TRAIL and 5-FU through the mitochondrial apoptosis pathway, Oncogene, vol.23, issue.50, pp.8320-8352, 2004. ,
DOI : 10.1038/sj.onc.1207971
Chemotherapy and TRAIL-mediated colon cancer cell death: the roles of p53, TRAIL receptors, and c-FLIP, Molecular Cancer Therapeutics, vol.4, issue.12, pp.2026-2062, 2005. ,
DOI : 10.1158/1535-7163.MCT-05-0262
Multivalent DR5 peptides activate the TRAIL death pathway and exert tumoricidal activity . Cancer research, pp.1101-1111, 2010. ,
URL : https://hal.archives-ouvertes.fr/hal-00451170
Phase 1b Study of Dulanermin (recombinant human Apo2L/TRAIL) in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Patients With Advanced Non-Squamous Non???Small-Cell Lung Cancer, Journal of Clinical Oncology, vol.28, issue.9, pp.1527-1560, 2010. ,
DOI : 10.1200/JCO.2009.25.4847
Expression of TRAIL (TNF-related apoptosis-inducing ligand) and its receptors in normal colonic mucosa, adenomas, and carcinomas, The Journal of Pathology, vol.20, issue.3, pp.327-362, 2003. ,
DOI : 10.1002/path.1364
Prognostic significance of tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) receptor expression in patients with breast cancer, Journal of Molecular Medicine, vol.7, issue.3, pp.995-1007, 2009. ,
DOI : 10.1007/s00109-009-0510-z
Prognostic significance of TRAIL-R1 and TRAIL-R3 expression in metastatic colorectal carcinomas, European Journal of Cancer, vol.44, issue.15, pp.2312-2320, 2008. ,
DOI : 10.1016/j.ejca.2008.06.042
URL : https://hal.archives-ouvertes.fr/inserm-00318854
Non-genetic origins of cell-to-cell variability in TRAIL-induced apoptosis, Nature, vol.382, issue.7245, pp.428-460, 2009. ,
DOI : 10.1038/nature08012
Increased death receptor 5 expression by chemotherapeutic agents in human gliomas causes synergistic cytotoxicity with tumor necrosis factor-related apoptosis-inducing ligand in vitro and in vivo, Cancer research, vol.60, issue.4, pp.847-53, 2000. ,
The Essential Role of the Mitochondria-Dependent Death-Signaling Cascade in Chemotherapy-Induced Potentiation of Apo2L/TRAIL Cytotoxicity in Cultured Thoracic Cancer Cells, The Cancer Journal, vol.12, issue.4, pp.257-73, 2006. ,
DOI : 10.1097/00130404-200607000-00004
Mitochondria-dependent and -independent mechanisms in tumour necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis are both regulated by interferon-?? in human breast tumour cells, Biochemical Journal, vol.365, issue.3, pp.825-857, 2002. ,
DOI : 10.1042/bj20020184
c-FLIP: a key regulator of colorectal cancer cell death . Cancer research, pp.5754-62, 2007. ,
Activated human NK and CD8+ T cells express both TNF-related apoptosis-inducing ligand (TRAIL) and TRAIL receptors but are resistant to TRAIL-mediated cytotoxicity, Blood, vol.104, issue.8, pp.2418-2442, 2004. ,
DOI : 10.1182/blood-2004-04-1294
Doxorubicin enhances TRAIL-induced cell death via ceramide-enriched membrane platforms, Apoptosis, vol.314, issue.8 ,
DOI : 10.1007/s10495-007-0081-9
Oxaliplatin enhances TRAIL-induced apoptosis in gastric cancer cells by CBL-regulated death receptor redistribution in lipid rafts, FEBS Letters, vol.6, issue.5, pp.943-951, 2009. ,
DOI : 10.1016/j.febslet.2009.02.014
c-FLIP inhibits chemotherapy-induced colorectal cancer cell death, Oncogene, vol.106, issue.6, pp.838-886, 2006. ,
DOI : 10.1016/S1074-7613(00)80214-9
Fas Ligand-independent, FADD-mediated Activation of the Fas Death Pathway by Anticancer Drugs, Journal of Biological Chemistry, vol.274, issue.12, pp.7987-92, 1999. ,
DOI : 10.1074/jbc.274.12.7987
Cisplatin-induced apoptosis involves a Fas-ROCK-ezrin-dependent actin remodelling in human colon cancer cells, European Journal of Cancer, vol.46, issue.8, 2010. ,
DOI : 10.1016/j.ejca.2010.01.034
URL : https://hal.archives-ouvertes.fr/hal-00659626
Bid Participates in Genotoxic Drug-Induced Apoptosis of HeLa Cells and Is Essential for Death Receptor Ligands' Apoptotic and Synergistic Effects, PLoS ONE, vol.26, issue.4, p.2844, 2008. ,
DOI : 10.1371/journal.pone.0002844.g011
Overexpression of FLIPL Is an Independent Marker of Poor Prognosis in Colorectal Cancer Patients, Clinical Cancer Research, vol.13, issue.17, pp.5070-5075, 2007. ,
DOI : 10.1158/1078-0432.CCR-06-2547
Tumor necrosis factor-related apoptosis inducing ligand-R4 decoy receptor expression is correlated with high Gleason scores, prostate-specific antigen recurrence, and decreased survival in patients with prostate carcinoma, Urologic Oncology: Seminars and Original Investigations, vol.26, issue.2, pp.158-65, 2008. ,
DOI : 10.1016/j.urolonc.2007.01.022
Production of Recombinant TRAIL and TRAIL Receptor: Fc Chimeric Proteins, Methods Enzymol, vol.322, pp.325-370, 2000. ,
DOI : 10.1016/S0076-6879(00)22031-4
Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line, Nucleic Acids Research, vol.18, issue.12, pp.3587-96, 1990. ,
DOI : 10.1093/nar/18.12.3587
BCL-2, BCL-XL Sequester BH3 Domain-Only Molecules Preventing BAX- and BAK-Mediated Mitochondrial Apoptosis, Molecular Cell, vol.8, issue.3, pp.705-716, 2001. ,
DOI : 10.1016/S1097-2765(01)00320-3
URL : http://doi.org/10.1016/s1097-2765(01)00320-3